Fixed Price IPO | ₹9 Cr | Listed at NSE SME | Thu, Aug 31, 2023 - Tue, Sep 5, 2023
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
Saroja Pharma Industries India Limited peer comparison with similar listed entities. () (As on March 31, 2023)
| Company Name | EPS (Rs) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | |
|---|---|---|---|---|---|
| EPS Basic | EPS Diluted | ||||
| Saroja Pharma Industries India Limited | 3.61 | 3.61 | 17.33 | 23.27 | 20.85 |
| NGL Fine Chem Limited | 84.57 | 84.57 | 334.35 | 23.15 | 25.29 |
| Sequent Scientific Limited | 0.60 | 0.60 | 41.92 | 223.00 | 1.42 |
1 Based on March 31st, 2023 restated financials statements.
2 Source: Annual Report of Peer Group Companies available on Stock Exchange.
3 Basic & diluted Earnings per share (EPS) is calculated in weighted average number of shares after considering Bonus Issue of Shares.
4 Price Earing (P/E) Ratio in relation to offer Price of ₹ 84/- per shares.
Saroja Pharma IPO Reviews, analysis and views by popular members.
| Review By | Apply | May Apply | Not Rated | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO Live News |
| IPO Allotment Status |
| IPO Basis of Allotment Document |
| IPO FAQs |
